EPR Cancer Research Results
EPR, enhanced permeability and retention (EPR) effect: Click to Expand ⟱
| Source: |
| Type: |
Passive accumulation (in cells) is based on the unique architecture of the tumor tissue, where neo-angiogenesis leads to an atypical endothelial layer and to fenestrated vasculature, which together with the impaired lymphatic drainage guides the penetration and accumulation of nano-sized materials within the cancerous tissues.
Exploited for drug design in the nanomedicine field.
|
PC, Pancreatic Cancer: Click to Expand ⟱
Pancreatic Cancer: Hypoxia (low oxygen tension) is commonly found in solid tumors. Hypoxia-inducible factor-1 (HIF-1),is a key mediator of the cellular response to hypoxia and is overexpressed in a wide variety of solid tumors, including pancreatic cancer.
Nanog is highly expressed in CSCs compared to normal cells [93–97]
HIF-1↑
|
Scientific Papers found: Click to Expand⟱
eff↑, uPA↓, uPAR↓, p‑EGFR↓, VEGFR1↓, NF-kB↓, IKKα↓, MMP2↓, MMP9↓, TIMP2↑, TumCP↓, IGFR↓, Akt↓, ERK↓, TumCCA↓, BAX↑, BAD↑, FasL⇅, Cyt‑c↑, EPR↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
Akt↓, 1, BAD↑, 1, BAX↑, 1, Cyt‑c↑, 1, FasL⇅, 1,
Cell Cycle & Senescence ⓘ
TumCCA↓, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, IGFR↓, 1,
Migration ⓘ
MMP2↓, 1, MMP9↓, 1, TIMP2↑, 1, TumCP↓, 1, uPA↓, 1, uPAR↓, 1, VEGFR1↓, 1,
Angiogenesis & Vasculature ⓘ
p‑EGFR↓, 1, EPR↑, 1,
Immune & Inflammatory Signaling ⓘ
IKKα↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1,
Clinical Biomarkers ⓘ
p‑EGFR↓, 1,
Total Targets: 21
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: EPR, enhanced permeability and retention (EPR) effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:21 Cells:% prod#:% Target#:612 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page